Encephalitis and adenine arabinoside: an indictment without fact. NIAID Collaborative Antiviral Study Group.
D002986:Clinical Trials as Topic; D035061:Control Groups; D004311:Double-Blind Method; D004341:Drug Evaluation; D004660:Encephalitis / Q000188:drug therapy* / Q000401:mortality; D026822:Ethicists; D004992:Ethics, Medical; D006561:Herpes Simplex / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D007065:Idoxuridine / Q000627:therapeutic use*; D033183:Interdisciplinary Communication; D009316:National Institutes of Health (U.S.); D018570:Risk Assessment; D014481:United States; D014740:Vidarabine / Q000009:adverse effects / Q000627:therapeutic use*
D014740:Vidarabine; D007065:Idoxuridine